tiprankstipranks
Trending News
More News >

Xeris Biopharma reports Q4 EPS (3c), consensus (2c)

Reports Q4 revenue $60.01M, consensus $58.54M. “The Xeris team executed an exceptional 2024 with record revenue topping $203 million,” said John Shannon, Xeris’ CEO. “The continued momentum of our commercial business, our exciting pipeline, along with our unrelenting focus on execution will enable Xeris to create even more value for patients and shareholders.”

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue